Membrane Bound O-Acyltransferase 7 (MBOAT7) Shapes Lysosomal Lipid Homeostasis and Function to Control Alcohol-Associated Liver Injury

Venkateshwari Varadharajan,Iyappan Ramachandiran,William J. Massey,Raghav Jain,Rakhee Banerjee,Anthony J. Horak 3rd,Megan R. McMullen,Emily Huang,Annette Bellar,Shuhui W. Lorkowski,Kailash Gulshan,Robert N. Helsley,Isabella James,Vai Pathak,Jaividhya Dasarathy,Nicole Welch,Srinivasan Dasarathy,David Streem,Ofer Reizes,Daniela S. Allende,Jonathan D. Smith,Judith Simcox,Laura E. Nagy,J. Mark Brown

DOI: https://doi.org/10.1101/2023.09.26.559533

2024-02-21

Abstract:Several recent genome-wide association studies (GWAS) have identified single nucleotide polymorphism (SNPs) near the gene encoding membrane-bound -acyltransferase 7 ( ) that is associated with advanced liver diseases. In fact, a common variant (rs641738), which is associated with reduced expression, confers increased susceptibility to non-alcoholic fatty liver disease (NAFLD), alcohol-associated liver disease (ALD), and liver fibrosis in those chronically infected with hepatitis viruses B and C. The gene encodes a lysophosphatidylinositol (LPI) acyltransferase enzyme that produces the most abundant form of phosphatidylinositol 38:4 (PI 18:0/20:4). Although these recent genetic studies clearly implicate MBOAT7 function in liver disease progression, the mechanism(s) by which MBOAT7-driven LPI acylation regulates liver disease is currently unknown. Previously we showed that antisense oligonucleotide (ASO)-mediated knockdown of promoted non-alcoholic fatty liver disease (NAFLD) in mice ( ). Here, we provide mechanistic insights into how loss of function promotes alcohol-associated liver disease (ALD). In agreement with GWAS studies, we find that circulating levels of metabolic product of MBOAT7 (PI 38:4) are significantly reduced in heavy drinkers compared to age-matched healthy controls. Hepatocyte specific genetic deletion ( ), but not myeloid-specific deletion ( ), of in mice results in enhanced ethanol-induced hepatic steatosis and high concentrations of plasma alanine aminotransferase (ALT). Given MBOAT7 is a lipid metabolic enzyme, we performed comprehensive lipidomic profiling of the liver and identified a striking reorganization of the hepatic lipidome upon ethanol feeding in mice. Specifically, we observed large increases in the levels of endosomal/lysosomal lipids including bis(monoacylglycero)phosphates (BMP) and phosphatidylglycerols (PGs) in ethanol-exposed mice. In parallel, ethanol-fed mice exhibited marked dysregulation of autophagic flux and lysosomal biogenesis when exposed to ethanol. This was associated with impaired transcription factor EB (TFEB)-mediated lysosomal biogenesis and accumulation of autophagosomes. Collectively, this works provides new molecular insights into how genetic variation in impacts ALD progression in humans and mice. This work is the first to causally link MBOAT7 loss of function in hepatocytes, but not myeloid cells, to ethanol-induced liver injury via dysregulation of lysosomal biogenesis and autophagic flux.

Pathology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is: How does membrane - bound O - acyltransferase 7 (MBOAT7) control the progression of alcohol - related liver damage (ALD) by regulating lysosomal lipid homeostasis and function? Specifically, the research aims to:

1. **Explore the role of MBOAT7 in humans**: By analyzing the differences in metabolites between drinkers and healthy control groups, verify whether the function of MBOAT7 is affected by alcohol intake.

2. **Clarify the cell - autonomous role of MBOAT7 in mice**: By constructing hepatocyte - specific knockout (Mboat7HSKO) and myeloid - cell - specific knockout (Mboat7MSKO) mouse models, explore the role of MBOAT7 in different cell types and its impact on alcohol - induced liver injury.

3. **Reveal the impact of MBOAT7 on the liver lipidome**: Through comprehensive lipidomics analysis, understand how MBOAT7 remodels the liver lipidome under alcohol - exposure conditions, especially the changes in lysosomal/endosomal lipids (such as BMP and PG).

4. **Elucidate the impact of MBOAT7 deletion on lysosomal function and autophagic flux**: By detecting the changes in TFEB - mediated lysosomal biogenesis and autophagic flux, reveal how MBOAT7 deletion leads to lysosomal dysfunction and autophagy defects, thereby promoting alcohol - induced liver injury.

Overall, this study aims to reveal the mechanism of action of MBOAT7 in alcohol - related liver diseases at the molecular and cellular levels, providing new insights into understanding how genetic variations affect the progression of ALD.